Tiagabine: efficacy and safety in partial seizures – current status
Jürgen Bauer, Déirdre Cooper-MahkornDepartment of Epileptology, Bonn University Hospital, GermanyAbstract: Tiagabine hydrochloride (TGB) is a selective gamma-aminobutyric acid (GABA) reuptake inhibitor. TGB is effective as an add-on medication in adults and children 12 ye...
Guardado en:
Autores principales: | Jürgen Bauer, Déirdre Cooper-Mahkorn |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5cfbeb7d45bc4e028fe12bcd568d236a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Lacosamide for the prevention of partial onset seizures in epileptic adults
por: Anna Kelemen, et al.
Publicado: (2010) -
An update on the toxicity of Aβ in Alzheimer’s disease
por: Jürgen Götz, et al.
Publicado: (2008) -
Disease-modifying therapies in relapsing–remitting multiple sclerosis
por: Fabricio González-Andrade, et al.
Publicado: (2010) -
Treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy
por: Stéphane Auvin
Publicado: (2007) -
Management of refractory complex partial seizures: current state of the art
por: David M Treiman
Publicado: (2010)